Addressing SARS-CoV-2 evolution: neutralization of emerging variants of concern by the AVX/COVID-12 'Patria' vaccine based on HexaPro-S ancestral Wuhan spike or its updated BA.2.75.2 version.
应对 SARS-CoV-2 的演变:AVX/COVID-12“Patria”疫苗基于 HexaPro-S 祖先武汉刺突蛋白或其更新的 BA.2.75.2 版本,可中和令人担忧的新出现的变异株
期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1565934
Carballo-Uicab Gregorio, Mellado-Sánchez Gabriela, González-González Edith, Salinas-Trujano Juana, Mendoza-Salazar Ivette, López-Olvera Karina, Gómez-Castellano Keyla M, Salazar Ma Isabel, Torres-Flores Jesús M, Chagoya-Cortés Héctor ElÃas, Paz-De la Rosa Georgina, Mena Ignacio, Rojas-MartÃnez Oscar, Lara-Puente Jesús Horacio, Peralta-Sánchez Gustavo Javier, Sarfati-Mizrahi David, Torres-Flores Alejandro, Sun Weina, Krammer Florian, GarcÃa-Sastre Adolfo, Palese Peter, López-MacÃas Constantino, Lozano-Dubernard Bernardo, Pérez-Tapia Sonia M, Almagro Juan C